Bio-markers for diagnosing diabetic retinopathy

摘要

The present invention relates to bio-markers for diagnosing diabetic retinopathy; and, more specifically, it pertains to a use of proteins, whose expression level down-regulated or up-regulated in the tears of a non-proliferative diabetic retinopathy (NPDR) patient, as bio-markers for diagnosing diabetic retinopathy, and a composition and kit for diagnosing diabetic retinopathy comprising antibodies against said proteins.